BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,910,000 | +67.8% | 16,879,000 | +121.3% | 0.00% | +50.0% |
| Q2 2020 | $10,076,000 | +130.5% | 7,627,000 | +84.7% | 0.00% | +100.0% |
| Q1 2020 | $4,371,000 | +157.3% | 4,130,000 | +163.7% | 0.00% | – |
| Q4 2019 | $1,699,000 | -33.2% | 1,566,000 | -36.5% | 0.00% | -100.0% |
| Q3 2019 | $2,543,000 | -22.4% | 2,466,000 | -16.1% | 0.00% | 0.0% |
| Q2 2019 | $3,279,000 | -22.1% | 2,939,000 | -20.8% | 0.00% | 0.0% |
| Q1 2019 | $4,207,000 | -5.8% | 3,710,000 | -7.6% | 0.00% | 0.0% |
| Q4 2018 | $4,464,000 | +10.9% | 4,014,000 | +19.5% | 0.00% | 0.0% |
| Q3 2018 | $4,024,000 | -21.5% | 3,358,000 | -23.8% | 0.00% | 0.0% |
| Q2 2018 | $5,124,000 | +39.0% | 4,409,000 | +32.2% | 0.00% | 0.0% |
| Q1 2018 | $3,686,000 | -45.4% | 3,336,000 | -40.9% | 0.00% | 0.0% |
| Q4 2017 | $6,754,000 | +15.8% | 5,645,000 | +16.2% | 0.00% | 0.0% |
| Q3 2017 | $5,834,000 | +0.8% | 4,858,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,787,000 | +11.1% | 4,858,000 | +11.1% | 0.00% | 0.0% |
| Q1 2017 | $5,209,000 | +0.3% | 4,373,000 | -0.1% | 0.00% | 0.0% |
| Q4 2016 | $5,194,000 | -7.9% | 4,377,000 | -3.0% | 0.00% | 0.0% |
| Q3 2016 | $5,642,000 | +13.2% | 4,513,000 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $4,986,000 | -7.5% | 4,355,000 | -3.5% | 0.00% | 0.0% |
| Q1 2016 | $5,392,000 | -9.0% | 4,512,000 | +2.5% | 0.00% | 0.0% |
| Q4 2015 | $5,927,000 | -50.1% | 4,402,000 | -50.2% | 0.00% | -66.7% |
| Q3 2015 | $11,872,000 | +18.5% | 8,842,000 | +40.5% | 0.00% | +50.0% |
| Q2 2015 | $10,018,000 | -13.1% | 6,291,000 | -17.4% | 0.00% | -33.3% |
| Q1 2015 | $11,528,000 | -6.7% | 7,612,000 | -24.5% | 0.00% | 0.0% |
| Q4 2014 | $12,350,000 | -1.0% | 10,076,000 | -11.6% | 0.00% | 0.0% |
| Q3 2014 | $12,479,000 | -21.7% | 11,396,000 | -24.7% | 0.00% | -25.0% |
| Q2 2014 | $15,941,000 | -3.6% | 15,137,000 | +1.6% | 0.00% | -20.0% |
| Q1 2014 | $16,539,000 | +54.7% | 14,900,000 | +49.0% | 0.01% | +66.7% |
| Q4 2013 | $10,693,000 | – | 10,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |